Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Rohn

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Brain Research|July 19, 2008
Caspase-cleaved TAR DNA-binding protein-43 is a major pathological finding in Alzheimer's diseaseTroy T Rohn
Oxidative Medicine and Cellular Longevity|March 28, 2013
The triggering receptor expressed on myeloid cells 2: "TREM-ming" the inflammatory component associated with Alzheimer's diseaseTroy T Rohn
International Journal of Clinical and Experimental Pathology|August 15, 2014
Is apolipoprotein E4 an important risk factor for vascular dementia?Troy T Rohn
CNS & Neurological Disorders Drug Targets|April 10, 2012
Targeting alpha-synuclein for the treatment of Parkinson's diseaseTroy T Rohn
International Journal of Neurology and Neurotherapy|November 10, 2015
Corpora Amylacea in Neurodegenerative Diseases: Cause or Effect?Troy T Rohn
International Journal of Molecular Sciences|July 23, 2013
Proteolytic cleavage of apolipoprotein E4 as the keystone for the heightened risk associated with Alzheimer's diseaseTroy T Rohn
Apoptosis : an International Journal on Programmed Cell Death|February 4, 2010
The role of caspases in Alzheimer's disease; potential novel therapeutic opportunitiesTroy T Rohn
Histology and Histopathology|June 26, 2009
Cytoplasmic inclusions of TDP-43 in neurodegenerative diseases: a potential role for caspasesTroy T Rohn
International Journal of Neurology and Neurotherapy|February 3, 2015
Caspase Cleaved Tau in Alzheimer's Disease: A Therapeutic Target RealizedTroy T Rohn
International Journal of Physiology, Pathophysiology and Pharmacology|April 23, 2010
Caspase-cleaved TAR DNA-binding protein-43 in Pick's diseaseTroy T Rohn, Polina Kokoulina
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Brain Research|July 19, 2008
Caspase-cleaved TAR DNA-binding protein-43 is a major pathological finding in Alzheimer's diseaseTroy T Rohn
Oxidative Medicine and Cellular Longevity|March 28, 2013
The triggering receptor expressed on myeloid cells 2: "TREM-ming" the inflammatory component associated with Alzheimer's diseaseTroy T Rohn
International Journal of Clinical and Experimental Pathology|August 15, 2014
Is apolipoprotein E4 an important risk factor for vascular dementia?Troy T Rohn
CNS & Neurological Disorders Drug Targets|April 10, 2012
Targeting alpha-synuclein for the treatment of Parkinson's diseaseTroy T Rohn
International Journal of Neurology and Neurotherapy|November 10, 2015
Corpora Amylacea in Neurodegenerative Diseases: Cause or Effect?Troy T Rohn
International Journal of Molecular Sciences|July 23, 2013
Proteolytic cleavage of apolipoprotein E4 as the keystone for the heightened risk associated with Alzheimer's diseaseTroy T Rohn
Apoptosis : an International Journal on Programmed Cell Death|February 4, 2010
The role of caspases in Alzheimer's disease; potential novel therapeutic opportunitiesTroy T Rohn
Histology and Histopathology|June 26, 2009
Cytoplasmic inclusions of TDP-43 in neurodegenerative diseases: a potential role for caspasesTroy T Rohn
International Journal of Neurology and Neurotherapy|February 3, 2015
Caspase Cleaved Tau in Alzheimer's Disease: A Therapeutic Target RealizedTroy T Rohn
International Journal of Physiology, Pathophysiology and Pharmacology|April 23, 2010
Caspase-cleaved TAR DNA-binding protein-43 in Pick's diseaseTroy T Rohn, Polina Kokoulina
Pageof 8